AndhraNews.net
Home » Features » Health » magnetic resonance imaging

magnetic resonance imaging


Recent Research and Developments on Magnetic Resonance Imaging (MRI)

magnetic resonance imaging in News

OxySure (OXYS) Appoints Territory Sales Managers in Midwest and Rocky Mountain Region
FRISCO, TX--(Marketwired - September 09, 2015) - OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other medical device solutions, today announced the appointment of two new Territory Sales Managers in Indiana and Colorado

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

3D Bioprinting Market Size to Reach $1.82 Billion by 2022: Grand View Research, Inc.
Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD), which demands kidney transplantation, is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation.

FONAR Announces Fiscal 2016 1st Quarter Financial Results
FONAR Corporation (NASDAQ: FONR)

Lupus Research Findings Provide Evidence of Progress and Hope for Improved Quality of Life Among People With Lupus
SAN FRANCISCO, CA--(Marketwired - November 07, 2015) - Data from lupus research studies supported by the Lupus Foundation of America (LFA) has provided evidence of progress and hope for solving the cruel mystery of lupus. Lupus experts presented study data during the American College of Rheumatology (ACR) Annual Scientific Meeting this week in San Francisco.

TiGenix: AlloCSC-01 Phase I data Presented at the Congress of the European Society of Cardiology
PRESS RELEASE

Optical Coherence Tomography Market Is to Grow at CAGR Of 9.8% From 2013 to 2019: Hexa Research Inc.
Optical Coherence Tomography has revealed its current usage in various applications and shows foreseeable usage in the near future. The report also discusses the usage of Optical Coherence Tomography techniques over other imaging techniques such as magnetic resonance imaging and ultrasound imaging

Facial Implants Market Worth $2.92 Billion by 2022: Grand View Research, Inc.
The global facial implant market is expected to reach USD 2.92 billion by 2022, according to a new report by Grand View Research, Inc. Increasing incidences of facial injuries, demand for non surgical facial rejuvenation surgery and the introduction of technologically advanced 3D printed implants for facial reconstruction are expected to drive the facial implant market over the forecast period.

TiGenix :TiGenix announces Cx601 meets primary endpoint in pivotal Phase III trial
Regulated information

New Consensus Recommendations Announced for Standardized Imaging Protocol in Brain Tumor Clinical Trials
The Jumpstarting Brain Tumor Drug Development Coalition (JBTDDC) today announced a new consensus protocol for magnetic resonance imaging (MRI) in brain tumor clinical trials to help better assess if a new treatment is effective

Three New Officers Elected to ASTRO's Board of Directors and Three New Members Selected for Nominating Committee
FAIRFAX, VA--(Marketwired - July 16, 2015) - The American Society for Radiation Oncology's (ASTRO's) members have elected three new officers to the Board of Directors and three members to serve on the Nominating Committee. Terms for all positions begin at the Annual Business Meeting on Tuesday, October 20, 2015 at 11:30 a.m. Central time, at ASTRO's 57th Annual Meeting at the Henry B

New data supporting gradual up-titration of ponesimod to mitigate first-dose cardiodynamic effects to be presented at EACPT 2015
Actelion Pharmaceuticals Ltd /New data supporting gradual up-titration of ponesimod to mitigate first-dose cardiodynamic effects to be presented at EACPT 2015 . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg
Novartis International AG /Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Expansion of Global MRI Systems Market Will Be Fuelled by Escalating Demand From Developing Economies
ALBANY, NY--(Marketwired - June 01, 2015) - ResearchMoz has announced a new addition to its database of research reports, titled “MRI Systems Market to 2020 (http://www.researchmoz.us/mri-systems-market-to-2020-focus-on-patient-comfort-and-operational-efficiency-with-growth-driven-by-developing-economies-report

Power Analytics, Booz Allen Hamilton, and Siemens to Conduct Microgrid Feasibility Study in New York
RALEIGH, NC--(Marketwired - May 12, 2015) - Partners Power Analytics (PA), Booz Allen Hamilton (BAH) and Siemens announced last Thursday that the Village of Sherburne, NY has awarded them a contract to study the feasibility of installing a community microgrid.

A New Book, "THE CRANIOCERVICAL SYNDROME AND MRI," Highlights the Unique Attributes of FONAR UPRIGHT MRI Imaging
FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announces the publication of a new book entitled "The Craniocervical Syndrome and MRI". It has been published by S. Karger, AG based in Basel, Switzerland (see www.karger.com/Book/Home/261956). Karger is a 125-year-old company, an academic publisher of scientific and medical journals and books.

Results From Lantheus Medical Imaging's First Phase 3 Study of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 Presented at ICNC12
N. BILLERICA, MA--(Marketwired - May 04, 2015) - Lantheus Medical Imaging, Inc

Hallmarq Veterinary MRI Receives Queens Award for Enterprise in Two Categories
ACTON, MA--(Marketwired - April 21, 2015) - Hallmarq Veterinary MRI has received two of the United Kingdom's most prestigious awards for outstanding and sustained business achievement. Hallmarq is one of only two companies this year to be awarded two accolades with the Queen's Award for Enterprise -- namely in international trade and innovation.

Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Novartis International AG /Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Sandoz receives FDA approval for GlatopaTM as the first generic competitor to MS therapy Copaxone® 20mg
Novartis International AG /Sandoz receives FDA approval for GlatopaTM as the first generic competitor to MS therapy Copaxone® 20mg . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Novartis announces presentation of data at AAN showing Gilenya® slowed the rate of brain volume loss in MS patients
Novartis International AG /Novartis announces presentation of data at AAN showing Gilenya® slowed the rate of brain volume loss in MS patients . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

3DIcon Submits Proposal to National Institutes of Health for an fMRI Interface
TULSA, OK--(Marketwired - December 09, 2014) - 3DIcon Corporation (OTC PINK: TDCP), a developer of groundbreaking 3D volumetric display technologies that are designed to produce full color, 360-degree volumetric high-resolution images, announced today it has met the deadline to submit a project proposal for funding to the National Institutes of Health (NIH).

FONAR Announces 1st Quarter Fiscal 2015 Results
FONAR Corporation (NASDAQ: FONR)

Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session
N. BILLERICA, MA--(Marketwired - September 18, 2014) - Lantheus Medical Imaging, Inc

Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
Novartis International AG /Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Gilenya® data at ACTRIMS-ECTRIMS to show Novartis is redefining MS treatment goals for patients
Novartis International AG /Gilenya® data at ACTRIMS-ECTRIMS to show Novartis is redefining MS treatment goals for patients . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Ortenzio Foundation & Select Medical Gift $1.25M to Kessler Foundation Neuroimaging & Rehab Research
The Rocco and Nancy Ortenzio Foundation and Select Medical have pledged a combined $1.25 million to support medical rehabilitation research at Kessler Foundation. In recognition of this generosity, Kessler Foundation will rename its Neuroimaging Center as the Rocco Ortenzio Neuroimaging Center at Kessler Foundation. Rocco A. Ortenzio is the co-founder and vice chairman of Select Medical.

Center for Diagnostic Imaging Is Indiana's First Healthcare Provider to Bring Wide-Bore 3T MRI to the Outpatient Setting
Center for Diagnostic Imaging (CDI) now offers patients outpatient access to a new MAGNETOM Skyra® 3T wide-bore MRI from Siemens Healthcare. As the widest 3T Magnetic Resonance Imaging (MRI) available, the scanner provides more room for claustrophobic or large/broad-shoulder patients in need of high-field imaging

Vishay Intertechnology Launches New SMD MLCC in Quad 2525 Case Size for High-Frequency RF Applications
Vishay Intertechnology, Inc. (NYSE: VSH) is adding to its QUAD HIFREQ series of high-power surface-mount multilayer ceramic chip capacitors (MLCCs) with a new device in the quad 2525 case size

FONAR UPRIGHT MRI Scan Leads to Successful Treatment for Former NFL Quarterback
FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported that after being diagnosed in November 2012 on the FONAR UPRIGHT® Multi-Position™ MRI (aka STAND-UP MRI®), former NFL quarterback, Jim McMahon, who suffered from post concussion dementia, was able to receive appropriate treatment and that his symptoms have resolved.

Sphere 3D and Overland Storage Enter Into Definitive Merger Agreement
Sphere 3D Corporation (TSX VENTURE: ANY) (OTCQX: SPIHF) ("Sphere 3D") and Overland Storage, Inc. (NASDAQ: OVRL) ("Overland") today announced that both companies' Boards of Directors have unanimously approved a definitive merger agreement under which the companies would combine to create a leading global virtualization and data management software solutions company

New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
Novartis International AG /New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

vRad and E-Techco Partnership Creates First Direct-to-Patient Remote Radiology Services in China
vRad (Virtual Radiologic), the nation's largest telemedicine company and radiology practice with over 450 physicians, today announced it completed a strategic partnership with E-Techco Information Technologies Co., Ltd. (E-Techco), a leader in consumer telehealth solutions

MRI-Guided Prostate Biopsy Improves Accuracy and Patient Comfort
During trial, a new MRI-guided prostate biopsy yielded more targeted prostate tissue retrieval and improved diagnosis accuracy

Diagnostic Imaging International Announces Expansion of Schuylkill Medical Imaging to Include Computerized Axial Tomography
Diagnostic Imaging International Corp. (OTCQB: DIIG) ("DIIG"), a provider of advanced fixed-base and remote medical diagnostic imaging services to clients across the U.S

Arkansas Radiology Group Selects Zotec Partners for Radiology Billing
INDIANAPOLIS, IN--(Marketwired - March 18, 2014) - Zotec Partners (Zotec), an industry-leading provider of radiology billing and practice management services, has been awarded an exclusive billing contract with Radiology Associates, P.A. (RAPA) in Little Rock, Ark.

Joint Statement From the Alliance for Integrity in Medicare Applauding IOAS Reform Proposal in the President's FY 2015 Budget

Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis
Celgene Corporation (NASDAQ:CELG) today announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in patients with active ankylosing spondylitis

TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis
TECFIDERA® (dimethyl fumarate) has been approved by the European Commission (EC) as a first-line oral treatment for people with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). Biogen Idec (NASDAQ: BIIB) will begin to introduce TECFIDERA in initial European Union (EU) countries in the coming weeks.

NuPathe Announces Allowance of Additional U.S. Patent for ZECUITY
NuPathe Inc. (NASDAQ: PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. Patent application 13/407,434. This application relates to NuPathe's innovative iontophoretic patch that uses a two-stage delivery sequence to transdermally deliver sumatriptan

NuPathe Announces Third Quarter 2013 Financial Results and Recent Operational Highlights
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended September 30, 2013, as well as recent operational highlights.

John Stamatos, M.D. Gives Chronic Pain Patient a New Lease on Life with Implantation of MRI-compatible Spinal Cord Stimulator
MELVILLE, NY--(Marketwired - October 31, 2013) - John Stamatos, M.D

Carson Family Makes Major Gift to Kessler Foundation to Improve Lives for People With Disabilities
Russell Carson, co-founder of Welsh, Carson, Anderson & Stowe and head of the Carson Family Charitable Trust, recently pledged $250,000 in unrestricted support to Kessler Foundation -- a major nonprofit organization in the field of rehabilitation research and disability employment.

Helix BioPharma Corp. Completes Data Review of First Four Cohorts of Its Phase I/II Clinical Study for Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed its interim review of the Company's ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland (the "LDOS002 Study")

New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
Novartis International AG /New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Grand Opening of the Neuroimaging Center at Kessler Foundation
The Neuroimaging Center at Kessler Foundation celebrates its grand opening on September 26. Kessler Foundation is now the only freestanding rehabilitation facility in the U.S. with a rehabilitation research-dedicated neuroimaging center.

NuPathe Doses Adolescent Migraineurs in Clinical Study of ZECUITY
NuPathe Inc. (NASDAQ: PATH) today announced the Company has initiated dosing of patients for NP101-015, a Phase 1 study of ZECUITY® (sumatriptan iontophoretic transdermal system) in adolescents with a history of migraine attacks. This open label, single-dose study will assess the safety, pharmacokinetics, and tolerability of ZECUITY in adolescent migraine patients

InnerVision Medical Technologies Develops Ultrasound Device to Image Morbidly Obese
InnerVision Medical Technologies, Inc., a developmental-stage company engaged in research and development of high-resolution ultrasound systems, today announced completion of its prototype ultrasound device and early evaluation results for imaging morbidly obese patients

OSMC First in Region to Perform Latest Procedure for Treating Back and Leg Pain
For years a medical technique called spinal cord stimulation has helped patients suffering from chronic back or leg pain find relief. The procedure involves implanting a small device -- a neurostimulator -- under the skin in the lower back. The device interrupts pain messages by sending out mild electrical impulses that reach the brain faster than the pain signal can arrive

NuPathe Announces Second Quarter 2013 Financial Results and Recent Operational Highlights
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended June 30, 2013, as well as recent operational highlights.

Imaging Healthcare Specialists to Renovate Its Golden Triangle Office to Enhance Patient Services
Imaging Healthcare Specialists, San Diego's leader in outpatient diagnostic imaging, is currently undergoing extensive renovations to implement the next generation of medical imaging at its Golden Triangle facility in La Jolla. The new state-of-the art imaging center was designed to significantly enhance the patient's experience and is expected to reopen in August 2013.

Overland Storage and Sphere 3D Deliver Revolutionary Technology Enabling Secure Access to Native Applications and Data Management on Any Device
Overland Storage (NASDAQ: OVRL), the trusted global provider of effortless data management and data protection solutions across the data lifecycle, in partnership with Sphere 3D Corporation (TSX VENTURE: ANY), developer of Glassware 2

Plexus and GE Healthcare Celebrate 30 Year Partnership

Global Medical Imaging Market to Spike to Over $35 Billion by 2019
TriMarkPublications.com cites in its newly published "Medical Imaging Markets" report that the global medical imaging market will spike to over $35 billion by 2019. For more information, visit: www.trimarkpublications.com/products/Medical-Imaging-Markets.html.

NuPathe to Present ZECUITY Data at the 2013 International Headache Congress
NuPathe Inc. (NASDAQ: PATH) today announced the Company will present data on ZECUITY® (sumatriptan iontophoretic transdermal system) at the upcoming International Headache Congress (IHC) 2013, which takes place June 27 to 30 in Boston, MA.

Switching to Novartis drug Gilenya from standard interferon shown to improve long-term outcomes for patients with multiple sclerosis
Novartis International AG /Switching to Novartis drug Gilenya from standard interferon shown to improve long-term outcomes for patients with multiple sclerosis . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Medtronic Announces CE Mark and Launch for CapSureFix Novus(TM) 5076 MRI Lead

The Ohio State University Commences Key Comparative Study of Vycor's Patented ViewSite(TM) Brain Access System (VBAS)
Vycor Medical, Inc

Medigene publishes final results from phase II Investigator Initiated Trial of EndoTAG®-1 at ASCO 2013
Medigene AG /Medigene publishes final results from phase II Investigator Initiated Trial of EndoTAG®-1 at ASCO 2013 . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Actelion's ponesimod successful in mid-stage trial in patients with moderate to severe chronic plaque psoriasis - Ponesimod to proceed to Phase III clinical development in psoriasis
Actelion Pharmaceuticals Ltd /Actelion's ponesimod successful in mid-stage trial in patients with moderate to severe chronic plaque psoriasis - Ponesimod to proceed to Phase III clinical development in psoriasis . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Cytomedix Announces Landmark Bright Cell Therapy Study in Peripheral Arterial Disease
Cytomedix, Inc. (OTCQX: CMXI) (the "Company"), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today the signing of an agreement with NIH to collaborate on a Phase 2 clinical study in patients with intermittent claudication (IC)

Imaging Healthcare Specialists Enjoys Successful Grand Re-Opening Event
On Saturday, September 29th Imaging Healthcare Specialists held a grand opening event to celebrate the opening of their newly expanded state-of-the-art medical imaging location in Encinitas, California. The event kicked off with a ribbon cutting ceremony by Encinitas Mayor Jerome Stocks followed by an appearance from former Chargers placekicker, John Carney, and the Charger Girls

Houston Hand Surgeon Evan D. Collins, M.D., Publishes Work in Orthopedic Reviews
Dr. Evan D. Collins, hand and upper extremity specialist in the Department of Orthopaedic Surgery at Methodist Hospital - Texas Medical Center, is featured in the leading medical journal Orthopedic Reviews

BIOTRONIK Demonstrates Its Commitment to Heart Failure Solutions With World's First MR Approved CRT Devices at ESC Congress 2012
BIOTRONIK, a leading manufacturer of innovative medical technology, is highlighting its broad, innovative and MRI (magnetic resonance imaging) approved implantable heart failure devices at the European Society of Cardiology congress, August 25-29, 2012.

"Development of Embolic Coils Using a Non-magnetic Alloy" by Tanaka Precious Metals and Others to be Adopted in a Project Commissioned by the Ministry of Economy, Trade and Industry
Tanaka Kikinzoku Kogyo K.K.(*1) (a company of Tanaka Precious Metals, Head office: Chiyoda-ku, Tokyo; President & CEO: Hideya Okamoto) today announced that the "Embolic Coils Using a Non-magnetic Alloy" jointly developed with Professor Hiroo Iwata and Research Fellow Tomonobu Kodama of the Kyoto University Institute for Frontier Medical Sciences and Maruho Hatsujyo Kogyo Co., Ltd

BIOTRONIK Celebrates 30-Year Anniversary -- Saving Thousands of Lives in Brazil
BIOTRONIK, a leading manufacturer of innovative medical technologies, is celebrating the thirtieth anniversary of its operations in Brazil. Since 1982, BIOTRONIK has been the only manufacturer of pacemakers, implantable cardioverter-defibrillators, stent technologies and devices which has remained in the country for 30 consecutive years.

Global Market for X-Rays to Spike to Over $9.0 Billion by 2017
TriMarkPublications.com cites in its newly published "Medical Imaging Markets" report that the global market for X-rays will spike to over $9.0 billion by 2017. For more information, visit: www.trimarkpublications.com/products/Medical-Imaging-Markets.html.

BIOTRONIK Presents World's Broadest Portfolio of Cardiac Devices Approved for MR Scans at Cardiostim 2012
BIOTRONIK's innovative new ProMRI® technology, which for the first time allows implantable cardiac defibrillator (ICD) and heart failure patients to undergo life-saving magnetic resonance imaging (MRI) scans, is scheduled to be showcased at the Cardiostim 2012, 18th World Congress in Nice, France, from June 13-16.

GE Healthcare Unveils an Exclusive 360 Degree Virtual Video Tour of London 2012 Olympic Village Polyclinic
Today GE Healthcare unveils a ‘one of a kind’ virtual video tour of the Olympic Village Polyclinic

Brain speller helps people unable to speak 'back-and-forth' communication
Researchers have developed a device that may enable people who are completely unable to speak or move at all to nevertheless manage unscripted back-and-forth conversation.

How brain guides human behaviour
Every day the human brain has to perform various tasks ranging from the trivial to the complex.

How humans learn to predict each other's decisions
Researchers in Japan have uncovered two brain signals in the human prefrontal cortex involved in how humans predict the decisions of other people.

Tense scenes in movies trigger brain activity
Findings of a research could lead to new ways for producers of films, television programs and commercials to predict what kinds of scenes their audiences will respond to.

How brain performs 'motor chunking' tasks revealed
Scientists have revealed the two-part process that seems to occur when our brain performs 'motor chunking' tasks, the findings that could have implications for the study and diagnosis of Parkinson's and other diseases of the motor system that involve action.

Altering brain chemistry may help overcome fear more easily
US researchers have found a way to calm the fears of anxious mice with the help of a drug that alters their brain chemistry.

Seeing pics of fatty foods and taking soda drinks ups hunger and cravings
Viewing pictures of high-fat foods and drinking sweetened beverages while viewing the pictures stimulate appetite and reward centers in the brain, which may contribute to overeating and obesity.

Meditation improves brain wiring in just one month
Researchers have found that just a month of meditation training alters brain wiring in ways that could open the door to new treatments for mental disorders.

Chinese meditation enhances brain function
Scientists studying the Chinese mindfulness meditation known as integrative body-mind training (IBMT) have confirmed and expanded their findings on changes in structural efficiency of white matter in the brain that can be related to positive behavioural changes in subjects practicing the technique regularly for a month.

Being in love makes one both blind and stupid
Love is not only blind, it also makes you stupid, a new research has claimed.

Larger posterior brain hippocampus linked to better memory
The sizes of the posterior and anterior segments of the hippocampus, an important brain structure associated with recollection memory, could predict individual's ability to remember past events, according to scientists.

Soon, 'Matrix-style' brain tech to learn high-performance tasks
Like in the Hollywood's "Matrix" franchise, it may be possible to use brain technology to learn to play a piano, reduce mental stress or hit a curve ball with little or no conscious effort, a new study has suggested.

'Aberrant' connectivity in brain behind depressive disorder
A new study has found that people with major depressive disorder (MDD) have abnormal connectivity between several key regions of the brain responsible for emotional behaviour, learning, memory and decision-making.

How our brain helps us remain focused
Scientists have discovered mechanisms that facilitate our brain to focus, by successfully directing only pertinent information to perceptual brain regions, a new study has suggested.

Being told painting is fake changes our brains' response to it
The way we perceive art is not 'rational' when it comes to judging between the fake and real thing, mainly because of a variety of influences and changes in brain pattern, a new study has suggested.

Is doing harm same as allowing harm?
People generally deal more sternly with people who are actively involved in committing harm than who are passively involved, but a conscious rationale is required to consider active and passive behaviours as equally wrong, if the harm caused is of the same level, researchers say.

Violent video games disrupt brain functioning in young men
Washington, Dec 1 : Playing violent video games can adversely affect brain functioning in young men, a new study has suggested. Washington, Dec 1 : Playing violent video games can adversely affect brain functioning in young men, a new study has suggested.

Abnormalities in brains of kids with ADHD identified
Researchers have identified abnormalities in the brains of children with attention deficit/hyperactivity disorder (ADHD) using functional magnetic resonance imaging (fMRI), that may serve as a biomarker for the disorder.

Novartis drug Gilenya® showed positive clinical outcomes for relapsing-remitting MS patients in third large Phase III clinical trial
Novartis International AG /Novartis drug Gilenya® showed positive clinical outcomes for relapsing-remitting MS patients in third large Phase III clinical trial . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

BIOTRONIK Introduces the World’s First and Only Implantable Defibrillators Eligible for Magnetic Resonance Imaging
BIOTRONIK, a leading manufacturer of innovative medical technology, announced the first implantations of the new Lumax 740 implantable cardiac defibrillators—the world’s first and only ICDs eligible for use with magnetic resonance imaging

Comment on this story

Share